about
Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cellsBone morphogenetic protein-9 is a circulating vascular quiescence factorProkineticins: new regulatory peptides in human reproductionAcquisition order of Ras and p53 gene alterations defines distinct adrenocortical tumor phenotypescAMP-dependent posttranscriptional regulation of steroidogenic acute regulatory (STAR) protein by the zinc finger protein ZFP36L1/TIS11bAU-rich elements and the control of gene expression through regulated mRNA stabilityThe multiple roles of EG-VEGF/PROK1 in normal and pathological placental angiogenesis.Influence of the umbilical cord insertion site on the optimal individual birth weight achievement.Basic fibroblast growth factor is a substrate for protein phosphorylation and is phosphorylated by capillary endothelial cells in culture.Noninvasive and quantitative assessment of in vivo fetomaternal interface angiogenesis using RGD-based fluorescence.Molecular characterization of EG-VEGF-mediated angiogenesis: differential effects on microvascular and macrovascular endothelial cells.Increased Trypanosoma cruzi invasion and heart fibrosis associated with high transforming growth factor beta levels in mice deficient in alpha(2)-macroglobulin.Azaindole derivatives are inhibitors of microtubule dynamics, with anti-cancer and anti-angiogenic activities.Uptake of host cell transforming growth factor-beta by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role in parasite cycle completion.Role of adrenocorticotropic hormone in the development and maintenance of the adrenal cortical vasculature.A new chemical inhibitor of angiogenesis and tumorigenesis that targets the VEGF signaling pathway upstream of RasCruzipain Activates Latent TGF-β from Host Cells during T. cruzi Invasion.BMP9 and BMP10 are necessary for proper closure of the ductus arteriosus.SB-431542, a transforming growth factor beta inhibitor, impairs Trypanosoma cruzi infection in cardiomyocytes and parasite cycle completion.BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.Differential effects of heparin, fibronectin, and laminin on the phosphorylation of basic fibroblast growth factor by protein kinase C and the catalytic subunit of protein kinase A.Antagonistic functions of tetradecanoyl phorbol acetate-inducible-sequence 11b and HuR in the hormonal regulation of vascular endothelial growth factor messenger ribonucleic acid stability by adrenocorticotropin.An EG-VEGF-dependent decrease in homeobox gene NKX3.1 contributes to cytotrophoblast dysfunction: a possible mechanism in human fetal growth restriction.Aberrant GPCR expression is a sufficient genetic event to trigger adrenocortical tumorigenesis.Expression of fibroblast growth factor receptor-2 splice variants is developmentally and tissue-specifically regulated in the amphibian embryo.Characterization of the adverse effects of nicotine on placental development: in vivo and in vitro studiesBone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formationProkineticin 2/Bv8 is expressed in Kupffer cells in liver and is down regulated in human hepatocellular carcinoma.Pivotal role for TGF-beta in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy.Insights into the role of genetic alterations in adrenocortical tumorigenesis.Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' diseaseAngiogenesis in adrenocortical physiology and tumor development.Emerging role of bone morphogenetic proteins in angiogenesis.The cAMP pathway regulates mRNA decay through phosphorylation of the RNA-binding protein TIS11b/BRF1.ACTH Action on Messenger RNA Stability Mechanisms.Dysregulation of microRNAs in adrenocortical tumors.The TGF-β pathway as an emerging target for Chagas disease therapy.Prokineticins in central and peripheral control of human reproduction.PPARγ controls pregnancy outcome through activation of EG-VEGF: new insights into the mechanism of placental development.EG-VEGF, BV8, and their receptor expression in human bronchi and their modification in cystic fibrosis: Impact of CFTR mutation (delF508).
P50
Q24309588-D9E4F8DC-E079-414C-B523-1D1B9646B411Q24657942-ECD155F1-995B-4913-B92E-66A0585066D2Q26823052-C529D639-9E23-426C-B328-C9A88F9C5710Q27333989-D17A5010-474C-4E95-8009-9557C0F13DB2Q28118974-743C4F61-F161-4578-825E-F500C5AA10DAQ28610137-339C7EDE-B2A1-4AAB-8B87-C0859799685EQ33735762-B1FD6BC5-BCEC-448A-9E33-B6BCFB9D49B7Q33748562-14EFF20A-399A-40FD-894E-062BF85EE738Q33852910-834ABC20-34A6-4F61-B161-D5BDF3230D4EQ33993285-13C9EED7-0A86-4DF5-B03A-5CD97D967A0EQ34063799-80C7E2B5-EE71-4A67-91A4-295F9A2F3DE7Q34129804-508826AB-1BF8-4FCC-9D6A-AE788B3D62E5Q34419792-D0B9948E-8E9A-49F6-B5F4-744021F9C79CQ35085273-3339464F-47CA-4E87-8615-4C5BB7E5C5B8Q35136717-F46194E0-02DC-4A0A-BE21-6519E4F177ACQ35572415-AA5D6924-2CBA-417D-A1DD-35DE41DE68DFQ35621418-AAD628B9-A794-4A1A-87A1-0C98242A5ABFQ35796190-49F1DB39-8453-493A-9460-192A004CFA5BQ35912705-E32A41C8-6E68-4DE6-9629-E3BB899B2FA0Q36057921-AD6A3CE0-6EBA-4418-8D98-9A1069504BA5Q36222306-DED4CE1D-A197-463B-A0D4-21AFEBF65936Q36407406-8EE93656-5967-4A23-93B2-86B72013DF5FQ36568308-01D2BE7B-D0DF-4CAE-BA3B-01E49A42474BQ36717562-E36AA38C-EBCF-4532-B45A-C1FAD315967BQ36733829-CB436713-B7BC-41B8-93DB-4A9215FC61D4Q36895981-4AD52540-5244-4D4F-AA1F-C667DB67F738Q37047011-F2ADC17F-9010-4046-99F1-161C20DE1A2EQ37212927-09DF9268-8D74-44AB-8D15-00F5737492F1Q37304464-4A46C490-F498-47AA-A3CD-6465D63B9455Q37325144-EEA10CE7-1017-421C-A384-8F7D69B3635BQ37409949-F44E13DD-928F-470D-A78E-B65DB95F8B9DQ37414884-FB2E1F85-F9AC-4CB0-9807-D391CFB1421DQ37510292-5EE3CB9D-CD25-4976-BFC2-CA3021663F27Q37518110-945E7A46-1C0C-4C4B-B0F0-8DD0C9BBB26FQ37595019-BE10A12A-C297-4FA3-8DAD-B309EE81CE97Q37945401-9DB573ED-C39C-4245-984C-58F1EE85A740Q38044657-550E7D46-6C8F-4644-A9AB-FDBB7E76B295Q38635211-26ABF92C-0E37-48B2-9F91-7D3972B59E14Q38863303-ABCC67CB-B05D-441C-8522-D53EDA61C55CQ38866990-2690819A-53A8-45FF-9341-87B2ABD931BA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jean-Jacques Feige
@ast
Jean-Jacques Feige
@en
Jean-Jacques Feige
@es
Jean-Jacques Feige
@nl
Jean-Jacques Feige
@sl
type
label
Jean-Jacques Feige
@ast
Jean-Jacques Feige
@en
Jean-Jacques Feige
@es
Jean-Jacques Feige
@nl
Jean-Jacques Feige
@sl
prefLabel
Jean-Jacques Feige
@ast
Jean-Jacques Feige
@en
Jean-Jacques Feige
@es
Jean-Jacques Feige
@nl
Jean-Jacques Feige
@sl
P1053
F-5534-2013
P106
P31
P496
0000-0002-1354-7692